Piramal Pharma share price
You have to be logged in to add this to Watchlist.Piramal Pharma is trading 2.92% upper at Rs 225.95 as compared to its last closing price. Piramal Pharma has been trading in the price range of 227.90 & 218.60. Piramal Pharma has given 58.15% in this year & 20.32% in the last 5 days.
Piramal Pharma has TTM P/E ratio 746.20 as compared to the sector P/E of 31.02.There are 5 analysts who have initiated coverage on Piramal Pharma. There are 3 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.
The company posted a net profit of -88.64 Crores in its last quarter.
Listed peers of Piramal Pharma include Kaynes Technology India (-1.50%), Global Health (-2.79%), Piramal Pharma (2.92%) etc.
Piramal Pharma has a 34.95% promoter holding & 64.58% public holding.The Mutual Fund holding in Piramal Pharma was at 2.43% in 30 Jun 2024. The MF holding has decreased from the last quarter. The FII holding in Piramal Pharma was at 13.41% in 30 Jun 2024. The FII holding has increased from the last quarter.
Piramal Pharma share price range
|
| ||||
|
| ||||
Piramal Pharma share Key Metrics
| Market Cap ( ₹ Cr.) | 28,974.55 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Piramal Pharma Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 26-Jul-24 | Quarterly Results |
| 10-May-24 | Audited Results & Final Dividend |
| 30-Jan-24 | Quarterly Results |
| 27-Oct-23 | Quarterly Results |
| 03-Aug-23 | Quarterly Results |
| 24-May-23 | Audited Results |
| 08-Feb-23 | Quarterly Results & Rights issue |
| 08-Nov-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 31-Jul-23 | 16-Jun-23 | AGM |
| 22-Mar-23 | 20-Feb-23 | POM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 10-May-24 | 12-Jul-24 | 12-Jul-24 | 0.11 |
| Announcement Date | Record Date | Ex-Rights Date | Ratio | FV | Description |
| 08-Feb-23 | 02-Aug-23 | 02-Aug-23 | 5:46 | 10 | Rights issue of equity shares of Rs. 10/- in the ratio of 5:46 @ premium of Rs. 71/-. |
FAQs about Piramal Pharma share price
Piramal Pharma is trading at 225.95 as on Fri Sep 06 2024 10:27:20. This is 2.92% upper as compared to its previous closing price of 219.55.
The market capitalization of Piramal Pharma is 29813.74 Cr as on Fri Sep 06 2024 10:27:20.
The average broker rating on Piramal Pharma is Strong Buy. The breakup of analyst rating is given below -
- 3 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 0 analysts have given a hold rating
- 0 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Piramal Pharma is 227.90 whereas the 52 wk low is 87.55
Piramal Pharma can be analyzed on the following key metrics -
- TTM P/E: 746.20
- Sector P/E: 31.02
- Dividend Yield: 0.05%
- D/E ratio: -
Piramal Pharma reported a net profit of 17.82 Cr in 2024.
Piramal Pharma Quick Links
Piramal Pharma Dividend Piramal Pharma Bonus Piramal Pharma News Piramal Pharma AGM Piramal Pharma Rights Piramal Pharma Splits Piramal Pharma Board Meetings Piramal Pharma Key Metrics Piramal Pharma Shareholdings Piramal Pharma Profit Loss Piramal Pharma Balance Sheet Piramal Pharma Cashflow Piramal Pharma Q1 Results Piramal Pharma Q2 Results Piramal Pharma Q3 Results Piramal Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks